Sarah Schoenfeld

Sarah Schoenfeld is currently the Associate VP for Medical and Scientific Strategy at BluPrint Oncology. Prior to this, Sarah held various roles at BGB Group and Icahn School of Medicine at Mount Sinai. With a Ph.D. in Environmental Health Science and Toxicology from Columbia University, Sarah has a strong background in research, publication, and scientific communication. Sarah has a history of successful collaborations with pharmaceutical clients, KOLs, and cross-functional teams, demonstrating a comprehensive understanding of medical and scientific strategy.